Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Peptide research brief BPC-157: mechanism, in vitro studies, and gaps in human evidence Common name BPC-157 Classification Synthetic peptide fragment (gastric pentadecapeptide) Sequence GEPPPGKPADDAGLV Molecular formula C62H98N16O22 Molecular weight 1419.55 Da CAS 137525-51-0 BPC-157: mechanism, in vitro studies, and gaps in human evidence The proposed bpc-157 mechanism of action centers on a pro-angiogenic signaling cascade reported across rodent and cell-culture experiments, with VEGFR2 receptor activation and downstream endothelial nitric oxide synthase (eNOS) phosphorylation as the most frequently cited nodes (Hsieh et al., 2017
Studies in bleomycin-induced pulmonary fibrosis show GHK administration at 2.6-260 g/mL/day reduces pathological TGF-1, preventing harmful fibrosis while maintaining beneficial tissue repair signals
Cagrilintide is designed to be more stable and is lipidated to extend its duration of action
It is not approved for human or veterinary consumption or for use in diagnostic or therapeutic procedures.
Semaglutide and tirzepatide are prescription-only medicines, available only through a licensed prescriber
/assets/images/provider/photos/2840805.png)
)
US$ 20.44
US$ 20.61
US$ 22.54
